RAdiopharmaceuticals - Handling and Packaging
RAdiopharmaceuticals - Handling and Packaging
• Diagnosing
• Designed to deliver therapeutic dose of
ionizing radiation to specific disease site,
such as cancerous tumors, with high
specificity in the body.
• If this radio nuclide has the same atomic number as one of the
nuclides already present in the molecule, the addition or
substitution is termed as isotope labeling.( eg sodium
iodohippurate in which some of the iodine -127 atoms have been
replaced by iodine -125 atoms)
•
Labelling
All products should be clearly identified by label which must
remain permanently attached to the containers under all
storage condition
The label on the container should show the;
a). Name of the drug product and product code,
b). The name of radio nuclide,
c). The name of manufacturer or the company,
d). The radioactivity per unit dose,
e). The route of administration,
f). The expiry date,
g). The amount of radioactivity at dispatch time and
h). In case of cold kits; -the direction of preparing and -a
statement of shelf life of the prepared radio pharmaceutical
and -the radiation dose that the patient would receive
Production and distribution records
• The processing records of regular production
batches must provide a complete account of the
manufacturing history of each batch of a radio
pharmaceutical, showing that it has been
manufactured, tested, dispersed into containers
and distributed in accordance.
• Separate records for the recent storage, use and
disposal of radio active products must be
maintained.
• Distribution records should be kept since the
return of radioactive products is not practical,
the purpose of recall procedures for such
products is to prevent their use rather than
actual return.
– Dispensing
• Side effects